Otsuka America Pharmaceutical INC
​Pharmaceutical Manufacturer.
Based in MD
🤖
AI Overview
With $420K in lobbying spend across 10 quarterly filings, Otsuka America Pharmaceutical INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2023.
$420K
Total Spend
3
Years Active
1
Firms Hired
5
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $20K |
| 2022 | $200K |
| 2023 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues
- •Prescription Digital Therapeutics Legislation and Mental Health policies under Medicare.
- •Issues related to Mental Health policies.
- •Issues related to prescription drug pricing.
- •Issues related to Medicare Part D redesign and impact on Low Income Subsidy beneficiaries.
- •Issues related to prescription drug pricing. Issues related to Medicare Part D redesign and impact on Low Income Subsidy beneficiaries.
- •Issues related to Mental Health policies. HR 7051 - Access to Prescription Digital Therapeutics Act.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
Plasma Protein Therapeutics Association
$4.8M total spend
Digestive Health Physicians Association, INC.
$2.0M total spend
American Society of Addiction Medicine
$1.9M total spend
Association for Molecular Pathology
$1.5M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.